Opinion: Restoring the renal microvasculature to treat chronic kidney disease

Nature Reviews Nephrology

Volumn 8, Issue 4, 2012, Pages 244-250

  Long, David A ^a   Norman, Jill T ^b   Fine, Leon G ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; COMP ANGIOPOIETIN 1; GROWTH FACTOR; MICRORNA; MICRORNA 132; RECOMBINANT ANGIOPOIETIN 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN A[1-121]; ANGIOGENIC FACTOR;

ADOPTIVE TRANSFER; ANGIOGENESIS; CELL INTERACTION; CHRONIC KIDNEY DISEASE; ENDOTHELIAL PROGENITOR CELL; HUMAN; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; MICROVASCULARIZATION; MICROVASCULATURE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; TISSUE REGENERATION; ARTICLE; CHRONIC KIDNEY FAILURE; CONVALESCENCE; DRUG EFFECT; KIDNEY CIRCULATION; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION;

ADOPTIVE TRANSFER; ANGIOGENESIS INDUCING AGENTS; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; RECOVERY OF FUNCTION; REGENERATION; RENAL CIRCULATION; RENAL INSUFFICIENCY, CHRONIC;

EID: 84858998542     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2011.219     Document Type: Review

References (52)

1. Coresh, J., Astor, B. C., Greene, T., Eknoyan, G. & Levey, A. S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 41, 1-12 (2003).
2. Fine, L. G., Orphanides, C. & Norman, J. T. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int. Suppl. 65, S74-S78 (1998).
3. Nangaku, M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. 17, 17-25 (2006).
4. Carmeliet, P. & Jain, R. K. Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307 (2011).
5. Maeshima, Y. & Makino, H. Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair 3, 13 (2010).
6. Mayer, G. Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease. Nephrol. Dial. Transplant. 26, 1132-1137 (2011).
7. Kang, D. H., Hughes, J., Mazzali, M., Schreiner, G. F. & Johnson, R. J. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J. Am. Soc. Nephrol. 12, 1448-1457 (2001).
8. Iliescu, R., Fernandez, S. R., Kelsen, S., Maric, C. & Chade, A. R. Role of renal microcirculation in experimental renovascular disease. Nephrol. Dial. Transplant. 25, 1079-1087 (2010).
9. Kim, W. et al. COMP-Angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J. Am. Soc. Nephrol. 17, 2474-2483 (2006).
10. Long, D. A. et al. Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Kidney Int. 74, 300-309 (2008).
11. Sato, W. et al. Selective stimulation of VEGFR2 accelerates progressive renal disease. Am. J. Pathol. 179, 155-166 (2011).
12. Schrijvers, B. F. et al. Pathophysiological role of vascular endothelial growth factor in the remnant kidney. Nephron Exp. Nephrol. 101, e9-e15 (2005).
13. Nakagawa, T., Kosugi, T., Haneda, M., Rivard, C. J. & Long, D. A. Abnormal angiogenesis in diabetic nephropathy. Diabetes 58, 1471-1478 (2009).
14. Saito, D. et al. Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis. Am. J. Physiol. Renal Physiol. 300, F873-F886 (2011).
15. Leonard, E. C., Friedrich, J. L. & Basile, D. P. VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am. J. Physiol. Renal Physiol. 295, F1648-F1657 (2008).
16. Mu, W. et al. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism. Am. J. Physiol. Renal Physiol. 296, F145-F152 (2009).
17. Bottinger, E. P. TGF-beta in renal injury and disease. Semin. Nephrol. 27, 309-320 (2007).
18. Kawai, H. et al. Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. Am. J. Pathol. 165, 1603-1612 (2004).
19. Denby, L. et al. Development of renal-targeted vector through combined in vivo phage display and capsid engineering of adenoviral fibers from serotype 19p. Mol. Ther. 15, 1647-1654 (2007).
20. Korpisalo, P. et al. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy. Eur. Heart J. 32, 1664-1672 (2011).
21. Nagy, J. A. et al. Permeability properties of tumor surrogate blood vessels induced by VEGF.-A. Lab. Invest. 86, 767-780 (2006).
22. Gavard, J., Patel, V. & Gutkind, J. S. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell 14, 25-36 (2008).
23. Elson, D. A. et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1. Genes Dev. 15, 2520-2532 (2001).
24. Tanaka, T. et al. Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab. Invest. 85, 1292-1307 (2005).
25. Higgins, D. F. et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117, 3810-3820 (2007).
26. 165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 62, 4123-4131 (2002).
27. 165b, an inhibitory splice variant of vascular endothelial growth factor leads to insufficient angiogenesis in patients with systemic sclerosis. Circ. Res. 109, e14-e26 (2011).
28. Ghosh, G. et al. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J. Clin. Invest. 120, 4141-4154 (2010).
29. Anand, S. et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angigogenesis. Nat. Med. 16, 909-914 (2010).
30. Dwivedi, R. S., Herman, J. G., McCaffrey, T. A. & Raj, D. S. Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int. 79, 23-32 (2011).
31. Jakobsson, L. et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell. Biol. 12, 943-953 (2010).
32. Lin, S. L. et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am. J. Pathol. 178, 911-923 (2011).
33. Armulik, A., Abramsson, A. & Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 97, 512-523 (2005).
34. Chen, J. et al. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int. 74, 879-889 (2008).
35. Bussolati, B. et al. Isolation of renal progenitor cells from adult human kidney. Am. J. Pathol. 166, 545-555 (2005).
36. Yasuda, K. et al. Adriamycin nephropathy, a failure of endothelial progenitor cell-induced repair. Am. J. Pathol. 176, 1685-1695 (2010).
37. Oliver, J. Architecture of the kidney in chronic Bright's disease (Paul B. Hoeber Inc., New York, 1939).
38. Fine, L. G. First heal thyself: Rescue of dysfunctional endothelial progenitor cells restores function to the injured kidney. Am. J. Pathol. 176, 1586-1587 (2010).
39. Asahara, T. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967 (1997).
40. Grant, M. B. et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8, 607-612 (2002).
41. Hirschi, K. K., Ingram, D. A. & Yoder, M. C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 28, 1584-1595 (2008).
42. Goligorsky, M. S., Yasuda, K. & Ratliff, B. Dysfunctional endothelial progenitor cells in chronic kidney disease. J. Am. Soc. Nephrol. 21, 911-919 (2010).
43. Togel, F., Issac, J., Hu, Z., Weiss, K. & Westernfelder, C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 67, 1772-1784 (2005).
44. Chade, A. R. et al. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 28, 1039-1047 (2010).
45. Zhu, X. Y. et al. Enhanced endothelial progenitor cell angiogenic potency, present in early experimental renovascular hypertension, deteriorates with disease duration. J. Hypertens. 29, 1972-1979 (2011).
46. Krenning, G. et al. Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. Am. J. Physiol. Renal Physiol. 296, F1314-F1322 (2009).
47. Sangidorj, O. et al. Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model. Am. J. Physiol. Renal Physiol. 299, F325-F335 (2010).
48. Chade, A. R. et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 119, 547-557 (2009).
49. Medici, D. et al. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat. Med. 16, 1400-1406 (2010).
50. Yoon, C.-H. et al. Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment. Circulation 121, 2001-2011 (2010).
51. Sakamoto, I. et al. Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int. 75, 828-838 (2009).
52. Matsui, K. et al. Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J. Am. Soc. Nephrol. 14, 1981-1989 (2003).